News Daily News Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab L.A. McKeown September 07, 2021
News Conference News ESC 2021 OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT Shelley Wood September 02, 2021
Presentation ESC 2021 One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome: Presenter: Hirotoshi Watanabe August 31, 2021
News Conference News In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS Shelley Wood August 30, 2021
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Conference News ESC 2021 Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5 Todd Neale August 24, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Early Recurrent Events After Acute MI: Clues to Origins Hint at Solutions Caitlin E. Cox August 10, 2021
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Daily News Predictors of Device-Related Thrombus Following LAA Occlusion Shelley Wood July 19, 2021
News Daily News De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis Yael L. Maxwell July 16, 2021
News Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS Yael L. Maxwell July 13, 2021
News Daily News ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority Yael L. Maxwell July 01, 2021
News Daily News FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk Michael O'Riordan June 30, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021